| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.31 | 9e-11 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |